Replies to post #117907 on Biotech Values

[ariadndndough]

gdollasign goodluck to both of us on it. i think we will get a run which looks to have started already going into mid may. i like my chances here very much good drug with a very large market.

go aria go amrn

dough

[mcbio]

After a few day of waffling between MNTA, NKTR and AMRN, I just pulled the trigger on AMRN. Love the 26% insider ownership and the 26% increase of institutional holdings last qtr. The market is massive and we shall see. Thanks for your input.

No way I would have picked AMRN over MNTA but good luck to you and hope things work out for you. With MNTA, you already have a big-selling drug approved and bringing in nice cash plus several other ways to win in generic Copaxone, FOBs, M118, etc. With AMRN, if you don't get positive ANCHOR results, you face the likelihood of being in the hole (possibly in a big way).

[RC2]

gdollasign: re AMRN's "26% insider ownership"

just curious where you found this number -- I've seen numbers all over the place, literally from 59% on MSN to 0.01% on Finviz...